drugset / Trial / NCT00449865

NET-PD LS-1 Creatine in Parkinson's Disease

NCT00449865

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this trial is to determine if the nutritional supplement creatine slows the progression of Parkinson's disease over time.

Timeline

Start
2007-03
Primary completion
2013-09
Completion
2014-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Creatine Other / unclassified 5 g

Indications